These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The importance of monitoring colorectal adenomas by tumor markers (ROC analysis). Stajic S, Novaković R, Kostić N, Josifovski J, Simić P, Katić V, Kovijanić M. Med Pregl; 1993; 46 Suppl 1():69-71. PubMed ID: 8569613 [Abstract] [Full Text] [Related]
4. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis]. Vallejo J, Torres-Avisbal M, Contreras P, Rodríguez-Liñán M, Rebollo A, González F, Benítez A, Infante J, Mateo A. Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111 [Abstract] [Full Text] [Related]
5. [The value of tumor markers in colorectal cancer]. Peters KM, Grundmann R. Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234 [Abstract] [Full Text] [Related]
15. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. Chen C, Chen LQ, Yang GL, Li Y. Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322 [Abstract] [Full Text] [Related]
18. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer. Koelbl H, Schieder K, Neunteufel W, Bieglmayer C. Neoplasma; 1989 Nov; 36(4):473-8. PubMed ID: 2770933 [Abstract] [Full Text] [Related]